Paper23944302
Primary hyperoxaluria.
Cochat P and 1 other. N Engl J Med, 2013. Cited by 444 papers, by iCite.
Cite this record
ConductScience Library. Primary hyperoxaluria. Papers, record 23944302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23944302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperoxaluria, Primary | Major topic |
| Kidney Transplantation | Major topic |
| Liver Transplantation | Major topic |
| Age of Onset | |
| Calcium Oxalate | |
| Humans | |
| Kidney Calculi | |
| Kidney Failure, Chronic |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04756024 | Reference Interval of Spot Urinary Oxalate to Creatinine Ratio in Children | Results |
Source ClinicalTrials.gov
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 24283239 | Primary hyperoxaluria. | https://conductscience.org/library/papers/24283239 | PubMed |
| Comment in | 24283240 | Primary hyperoxaluria. | https://conductscience.org/library/papers/24283240 | PubMed |
Cited by277
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 444 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42792949 | Mutational Landscape of Primary Hyperoxaluria in Morocco: Update and Implications for Diagnosis. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42792949 | PubMed |
| 42737782 | Animal Models of Hyperoxaluria and Their Relevance for Fundamental Research and Clinical Practice. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737782 | PubMed |
| 42417999 | Reno-ocular syndromes: pathophysiological mechanisms linking kidney and ocular disorders. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/42417999 | PubMed |
| 42211689 | The Kidneys Went Nuts: Oxalate Nephropathy From Excessive Cashew Nut Consumption. | Kidney Med | 2026 | https://conductscience.org/library/papers/42211689 | PubMed |
| 42196567 | Targeting the Highly Deleterious G161C and Y260C SNP Variants of the AGXT Protein Involved in Glyoxylate Metabolism Using Tauroursodeoxycholic Acid: A Computational Study. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196567 | PubMed |
| 42164636 | Living Donor Kidney Transplantation in High-Recurrence Kidney Diseases: Precision Risk Stratification and Management. | Kidney Int Rep | 2026 | https://conductscience.org/library/papers/42164636 | PubMed |
| 42090673 | Primary Hyperoxaluria With Cardiac Involvement: A Case Series. | Arq Bras Cardiol | 2026 | https://conductscience.org/library/papers/42090673 | PubMed |
| 42002641 | Clinical and molecular spectrum of primary hyperoxaluria type 1 in Tunisia: pediatric presentation and minimum observed prevalence. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/42002641 | PubMed |
| 41972717 | Novel AAV843 Vector-Mediated Gene Replacement Therapy Rescues Primary Hyperoxaluria Type I in Mice. | Cells | 2026 | https://conductscience.org/library/papers/41972717 | PubMed |
| 41917895 | Urine microscopy revealing a metabolic disorder: a case report. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/41917895 | PubMed |
| 41682620 | Clinical Approaches and Emerging Therapeutic Horizons in Primary Hyperoxaluria. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682620 | PubMed |
| 41612493 | Steroid hormones and nephrolithiasis: regulation of urine components metabolism and inflammation. | Biol Sex Differ | 2026 | https://conductscience.org/library/papers/41612493 | PubMed |
| 41362524 | Acute Kidney Injury Secondary to Vitamin D Intoxication: A Case of Oxalate Nephropathy. | Cureus | 2025 | https://conductscience.org/library/papers/41362524 | PubMed |
| 41343248 | Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1. | Clin J Am Soc Nephrol | 2026 | https://conductscience.org/library/papers/41343248 | PubMed |
| 41330733 | Genetic Correction of the Most Common Mutation Causing Primary Hyperoxaluria Restores Enzyme Localization and Oxalate Metabolism. | J Inherit Metab Dis | 2026 | https://conductscience.org/library/papers/41330733 | PubMed |
| 41279363 | Modulating inter-mitochondrial contacts to increase membrane potential for mitigating blue light damage. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279363 | PubMed |
| 41209157 | Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study. | Kidney Med | 2025 | https://conductscience.org/library/papers/41209157 | PubMed |
| 41152954 | Primary hyperoxaluria: insights into its clinical presentation, genetic mutations, and transplantation outcomes in a pediatric population in a tertiary care center. | Orphanet J Rare Dis | 2025 | https://conductscience.org/library/papers/41152954 | PubMed |
| 41112343 | Piperacillin Pharmacokinetics in a Pediatric Patient With Primary Hyperoxaluria Receiving High-Dose Continuous Dialysis Post Liver-Kidney Transplant. | J Pediatr Pharmacol Ther | 2025 | https://conductscience.org/library/papers/41112343 | PubMed |
| 41102680 | Real-world burden of primary hyperoxaluria with chronic kidney disease in the United States: a retrospective administrative claims analysis. | BMC Nephrol | 2025 | https://conductscience.org/library/papers/41102680 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23944302
GET https://conductscience.org/api/papers/v1/23944302/cited_by?page=2